Chr Hansen Holding A/S (CHRH)

559.20
-1.40(-0.25%)
  • Volume:
    259,152
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    557.80 - 566.80

CHRH Overview

Prev. Close
560.6
Day's Range
557.8 - 566.8
Revenue
13.29B
Open
561
52 wk Range
504 - 734
EPS
12.09
Volume
259,152
Market Cap
73.64B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
326,429
P/E Ratio
46.26
Beta
0.5
1-Year Change
-8.48%
Shares Outstanding
131,686,267
Next Earnings Date
Jul 08, 2021
What is your sentiment on Chr Hansen Holding A/S?
or
Market is currently closed. Voting is open during market hours.

Chr Hansen Holding A/S News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellSell

Chr Hansen Holding A/S Company Profile

Chr Hansen Holding A/S Company Profile

Employees
3600
Market
Denmark

Chr Hansen Holding A/S is a Denmark-based bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The Company’s business is divided into three divisions, namely Food Cultures & Enzymes, Health & Nutrition and Natural Colors. The Food Cultures & Enzymes division develops and produces cultures, enzymes and probiotics for the food industry in general and the dairy industry in particular. The Health & Nutrition division develops, produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula and animal feed industries. The Natural Colors division develops and supplies natural color solutions to the food and beverage industry, in particular the beverage, confectionery, ice cream, dairy, fruit preparation and prepared food segments. The Company operates in Europe, North and South America, as well as Asia Pacific, Middle East and Africa.

Read More
  • strong company ... inviting and expanding ... always strong sales in Q1.. target next months 730
    0
    • target 700 next months
      0
      • Solid momentum continues: 9% organic growth in the first 6 months of 2018/19
        0
        • Solid organic revenue growth of 9% in the first half of 2018/19: Food Cultures & Enzymes 10%, Health & Nutrition 11% and Natural Colors 5%. EBIT before special items increased by 10% to EUR 150 million, corresponding to an EBIT margin before special items of 27.0% up 0.8%-point compared to last year. In Q2, organic growth was 8%, and EBIT before special items increased by 11%. The overall outlook for 2018/19 remains unchanged.
          0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.